Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Bluegreen who wrote (8926)	3/4/1999 10:35:00 AM
From: opalapril	Read Replies (1) \| Respond to of 17367

<Opal, that is hitting below the belt!> Sorry. I ddn't mean to hit anyone anywhere. As it is, we Xoma shareholders are black and blue enough. My concern about the wording of this FAQ is the subtle (and perhaps accidental) way it may convey the thinking of the writer. I read it as more or less dismissing any possibility of an interest by a large pharma -- on any terms. Such would not be consistent with the bravado that comes from confidence Neuprex/BPI will become a highly successful compound. Rather, it manifests a discouraged, whistle-past-the-graveyard attitude that one must assume comes from repeated rebuffs by potential partners over the long period we know, from past FAQs, Xoma said it was looking. Maybe the FAQ merely reflects an unfortunate choice of words born of a stunted education in the Bermuda educational system.